5 results match your criteria: "University of California Los Angeles Medical Center (G.C.F.).[Affiliation]"
Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure.
Circ Heart Fail
November 2024
Division of Cardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles Medical Center (G.C.F.).
Article Synopsis
- Fewer than 20% of heart failure patients with reduced ejection fraction receive all recommended treatments, highlighting the need to investigate disparities based on race, sex, and social factors for effective care.
- A study analyzed data from the American Heart Association's registry to evaluate how these disparities affect the optimization of quadruple therapy in heart failure patients between July 2021 and September 2023.
- Results showed that while Black and Hispanic patients had slightly higher therapy scores compared to non-Hispanic Whites, females performed better than males, and those without private insurance faced significantly lower optimization scores.
Generalizable Approach to Quantifying Guideline-Directed Medical Therapy.
Circ Heart Fail
May 2024
Healthcare Institute for Innovations in Quality, University of Missouri-Kansas City (M.S.K., P.S.C., C.F.S., N.I., A.J.S., J.A.S.).
Article Synopsis
- The Kansas City Medical Optimization (KCMO) score was developed to more accurately quantify the intensity of guideline-directed medical therapy (GDMT) for heart failure patients by averaging daily doses compared to target doses.
- In a study with over 4,500 patients, baseline scores showed low average KCMO (38.8), indicating underutilization of optimal therapy, while a 1-year follow-up revealed slight declines in scores, suggesting challenges in improving GDMT intensity.
- KCMO demonstrated the highest variability among scoring methods, implying it provides a clearer picture of differences in GDMT intensity among patients, but further research is needed to determine its impact on patient outcomes and quality of care.
Hospital at Home as a Treatment Strategy for Worsening Heart Failure.
Circ Heart Fail
October 2023
Division of Cardiology, Duke University Medical Center, Durham, NC (M.S.K., S.J.G.).
Hospital at home (HaH) is an innovative care model that may be particularly suited for heart failure (HF). Outpatient visits and inpatient care have been the 2 traditional settings for HF care, yet may not match the social and medical needs of patients at all times. Alternative models such as HaH may represent an effective and patient-centered option for select patients with worsening HF.
View Article and Find Full Text PDFOutcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry.
Circ Cardiovasc Interv
May 2020
Duke Clinical Research Institute, Durham, NC (J.P.P., D.N.H., R.B., E.D.P., S.V.R.).
Background: Patients with atrial fibrillation on oral anticoagulation (OAC) undergoing cardiac catheterization face risks for embolic and bleeding events, yet information on strategies to mitigate these risks in contemporary practice is lacking.
Methods: We aimed to describe the clinical/procedural characteristics of a contemporary cohort of patients with atrial fibrillation on OAC who underwent cardiac catheterization. Use of bleeding avoidance strategies and bridging therapy were described and outcomes including death, stroke, and major bleeding at 30 days and 1 year were compared by OAC type.
Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
Circ Heart Fail
July 2016
From the Duke Clinical Research Institute, Durham, NC (P.A.P., L.L., P.K., B.G.H., L.H.C., A.F.H.); Ronald Reagan University of California Los Angeles Medical Center (G.C.F.); Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (C.W.Y.); Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.); and Duke University Medical Center, Durham, NC (A.F.H.).
Background: Diabetes mellitus, heart failure (HF), and chronic kidney disease are common comorbidities, but overall use and safety of antihyperglycemic medications (AHMs) among patients with these comorbidities are poorly understood.
Methods And Results: Using Get With the Guidelines-Heart Failure and linked Medicare Part D data, we assessed AHM use within 90 days of hospital discharge among HF patients with diabetes mellitus discharged from Get With the Guidelines-Heart Failure hospitals between January 1, 2006, and October 1, 2011. We further summarized use by renal function and assessed renal contraindicated AHM use for patients with estimated glomerular filtration rate <30 mL/min/1.